Heidelberg Pharma and Roche sign license agreement for antibody-targeted amanitin conjugates Sep. 3, 2013 No Comments
RaQualia-Interprotein collaboration yields protein-protein interaction inhibitor hits Sep. 2, 2013 No Comments
The development of an optogenetic two-hybrid system for the control of mammalian gene transcription Aug. 28, 2013 No Comments
Shire and Santaris extend partnership to develop drugs for rare genetic diseases Aug. 23, 2013 No Comments
RSS